Union Health Minister launches first made-in-India intranasal Covid vaccine
The nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's (DCGI) approval in November for restricted emergency use among adults as a heterologous booster dose.
India's first intranasal Covid vaccine to be launched on Jan 26
In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 per shot for private vaccination centres.
Germany to recognise Covaxin for travel purpose from June 1, says envoy
In November last year, the World Health Organisation recommended Emergency Use Listing (EUL) status for Covaxin.
Documents for Covaxin emergency use listing submitted to WHO; expect approval at earliest: Bharat Biotech
WHO chief scientist Soumya Swaminathan had said that the global health body is likely to take a decision on Covaxin in the emergency use listing within four to six weeks.
If everything goes well India would get COVID-19 vaccine by year-end: Harsh Vardhan
Three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India.
Vizhinjam seaport protests: Police station attack was with 'ulterior intention', says Kerala CM
'The Kashmir Files' controversy: Apologies if my remarks were interpreted differently, says Nadav Lapid
Will fight again, against what is wrong: Bilkis Bano on remission given to her rapists
Tamil Nadu amended law that allows Jallikattu seeks to prevent cruelty on animals: State tells SC
India dismisses China's concerns on military exercise with US in Uttarakhand
'Bazball' powers England to new first-day record against Pakistan in 1st Test